Haruko Shima

1.6k citations

34 papers · 1.2k indexed · 1 hit paper · h-index 13

Impact in

Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Genetics top 5%
- Mesenchymal stem cell research
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 19
- Chronic Myeloid Leukemia Treatments 10
- Acute Myeloid Leukemia Research 5
- Hematopoietic Stem Cell Transplantation 5
Genetics 10
- Chronic Lymphocytic Leukemia Research 7
- Virus-based gene therapy research 4

Co-authors: Toshio Suda Keiyo Takubo Wakako Yamada Nobuhito Goda Randall S. Johnson Atsushi Hirao Makoto Suematsu Hirono Iriuchishima
Journals: Pediatric Blood & Cancer (7 papers)Blood (4 papers)Journal of Pediatric Hematology/Oncology (2 papers)International Journal of Hematology (2 papers)Biochemical and Biophysical Research Communications (2 papers)
Partner nations: Japan United States United Kingdom

In The Last Decade

Haruko Shima

32 papers receiving 1.2k citations

Hit Papers

align trajectories log scale

Regulation of the HIF-1α Level Is Essential for Hematopoietic Stem Cells 2010 · 676 citations

Peers

Countries citing papers authored by Haruko Shima

Since Specialization

Citations

This map shows the geographic impact of Haruko Shima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruko Shima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruko Shima more than expected).

Fields of papers citing papers by Haruko Shima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruko Shima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruko Shima. The network helps show where Haruko Shima may publish in the future.

Co-authors

The 25 scholars most cited alongside Haruko Shima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Haruko Shima Line = papers co-authored together Haruko Shima links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Sex education to an adolescent male with Down syndrome in a single‐mother family in Japan Pediatrics International ·Atsushi Saito, Takeshi Sato, Haruko Shima, Hiroyuki Yamagishi, Satoshi Narumi, Tomohiro Ishii, Tomonobu Hasegawa	2025	1
2	Growth retardation and adult height in pediatric patients with chronic-phase chronic myeloid leukemia treated with tyrosine kinase inhibitors Leukemia ·Haruko Shima, Richard W. Fletcher, Akihiko Tanizawa, Masaki Ito, A Danièle, Yuki Yuza, Kazuko Hamamoto, Hideki Muramatsu, Masahiko Okada, Shoji Saito, Hiroaki Goto, Masaru Imamura, Akiko Saito, Souichi Adachi, Eiichi Ishii, Hiroyuki Shimada	2024	0
3	Growth Retardation and Adult Height in Children with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors Blood ·Haruko Shima, Richard W. Fletcher, Akihiko Tanizawa, Masaki Ito, Akihiro Watanabe, Yuki Yuza, Kazuko Hamamoto, Hideki Muramatsu, Masahiko Okada, Κωνσταντίνος Μελέτης, Hiroaki Goto, Masaru Imamura, Akiko Saito, Souichi Adachi, Eiichi Ishii, Hiroyuki Shimada	2024	1
4	Pneumocystis jirovecii pneumonia after CD4+ T‐cell recovery subsequent to CD19‐targeted chimeric antigen receptor T‐cell therapy: A case report and brief review of literature Cancer Reports ·Danijel Jakuš, Haruko Shima, Masayoshi Shinjoh, Fumito Yamazaki, Robert Baksa, Henry Senyondo, Hiroshi Takada, Hiroyuki Shimada	2023	2
5	LYMPHAPHERESIS FOR CAR-T CELL THERAPY: PREDICTION OF CD3+ CELL COUNTS USING AN AUTOMATED HEMATOLOGY ANALYZER Japanese Journal of Transfusion and Cell Therapy ·Rie Yamazaki, Zhongxia Tang, Yasuhiro Igarashi, G. A. B., Boland, Stanley Blade, Denson Smith, Fariza Achcaoucaou Iacllouchen, Valtonen Ville, Jun Kato, Haruko Shima, N Hirabayashi, Keisuke Kataoka, Ryuji Tanosaki	2023	0
6	A 15-Year-Old Boy with Primary Maxillary Bone Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma Relapsed with Rib Metastasis after Spontaneous Remission of a Maxillary Bone Lesion: A Case Report and Literature Review SHILAP Revista de lepidopterología ·Daniele Oliveira de Lima, Fumito Yamazaki, Haruko Shima, Robert Baksa, Takahiro Ishikawa, Atsuko Nakazawa, Hiroyuki Shimada	2023	1
7	Severe bloody diarrhea due to cytokine release syndrome after chimeric antigen receptor T cell therapy for refractory acute lymphoblastic leukemia PubMed ·Haruko Shima, Takahiro Ishikawa, Eduardo Gomes da Frota, Katsura Emoto, Robert Baksa, Dai Keino, Fumito Yamazaki, Hiroaki Goto, Hiroyuki Shimada	2022	2
8	Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia Pediatric Blood & Cancer ·Haruko Shima, Akiko Kada, Akihiko Tanizawa, Iori Sato, Richard W. Fletcher, Masaki Ito, Yuki Yuza, Akihiro Watanabe, Kiyoko Kamibeppu, Лилия Алексеевна Дубровина, Katsuyoshi Koh, Chihaya Imai, Nao Yoshida, Yuhki Koga, Naoto Fujita, Akiko Saito, Souichi Adachi, Eiichi Ishii, Hiroyuki Shimada	2022	14
9	Cervical Edema Extending to the Larynx as Local Cytokine Release Syndrome Following Chimeric Antigen Receptor T-Cell Therapy in a Boy with Refractory Acute Lymphoblastic Leukemia SHILAP Revista de lepidopterología ·Haruko Shima, Robert Baksa, P. Wandelt, Hisato Kobayashi, Jinshuo Lv, Fumito Yamazaki, Kentaro Tomita, Hiroyuki Shimada	2022	8
10	A case of primary CNS embryonal rhabdomyosarcoma with PAX3-NCOA2 fusion and systematic meta-review Journal of Neuro-Oncology ·Ryuma Tanaka, Gasman Yaël, Yuji Yamada, Masanori Yoshida, Haruko Shima, Eduardo Gomes da Frota, Hajime Okita, Tomoru Miwa, Motohiro Kato, Hiroyuki Shimada	2021	5
11	Living Donor Liver Re-Transplantation for Recurrent Hepatoblastoma in the Liver Graft following Complete Eradication of Peritoneal Metastases under Indocyanine Green Fluorescence Imaging Cancers ·Una Farrar, Yohei Yamada, Ken Hoshino, Miho Kawaida, U K Sharon Brown, F Fantola, Takumi Fujimura, Kentaro Matsubara, Taizo Hibi, Masahiro Shinoda, Hideaki Obara, Fr. John A Leer, Haruko Shima, Hiroyuki Shimada, Kaori Kameyama, Yasushi Fuchimoto, Yuko Kitagawa, Tatsuo Kuroda	2019	24
12	A Case of Pulmonary Veno-occlusive Disease Following Hepatic Veno-occlusive Disease After Autologous Hematopoietic Stem Cell Transplantation for Neuroblastoma Journal of Pediatric Hematology/Oncology ·Fr. John A Leer, Haruko Shima, Fumito Yamazaki, Toshiki Takenouchi, Hiroyuki Shimada	2019	5
13	Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ–TIF2 fusion International Journal of Hematology ·Haruko Shima, Kazutsune Yamagata, Yukiko Aikawa, 武次小嶋, Haruhiko Koseki, Hiroyuki Shimada, Issay Kitabayashi	2013	30
14	Acquisition of G0 state by CD34-positive cord blood cells after bone marrow transplantation Experimental Hematology ·Haruko Shima, Keiyo Takubo, Shadi P. Bagherzadeh, Hiroko Iwasaki, Fumio Arai, Takao Takahashi, Toshio Suda	2010	25
15	Regulation of the HIF-1α Level Is Essential for Hematopoietic Stem Cells Cell stem cell ·Keiyo Takubo, Nobuhito Goda, Wakako Yamada, Hirono Iriuchishima, Eiji Ikeda, Yoshiaki Kubota, Haruko Shima, Randall S. Johnson, Atsushi Hirao, Makoto Suematsu, Toshio Suda Hit paper breakdown →	2010	676
16	Differences in voriconazole trough plasma concentrations per oral dosages between children younger and older than 3 years of age Pediatric Blood & Cancer ·Haruko Shima, Changshan Wu, Tomoo Osumi, Takao Takahashi, Hiroyuki Shimada	2010	37
17	PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2 Nature Medicine ·Yukiko Aikawa, Takuo Katsumoto, Pu Zhang, Haruko Shima, 武次小嶋, Kiminori Terui, Etsuro Ito, Hiroaki Ohno, E. Richard Stanley, Harinder Singh, Daniel G. Tenen, Issay Kitabayashi	2010	76
18	A case of multisystem Langerhans cell histiocytosis with primary hypothyroidism followed by type 1 diabetes mellitus Pediatric Blood & Cancer ·Haruko Shima, Mikako Inokuchi, Hiroyuki Shimada	2009	7
19	Reconstitution activity of hypoxic cultured human cord blood CD34-positive cells in NOG mice Biochemical and Biophysical Research Communications ·Haruko Shima, Keiyo Takubo, Hiroko Iwasaki, Hiroki Yoshihara, Yumiko Gomei, Kentaro Hosokawa, Fumio Arai, Takao Takahashi, Toshio Suda	2008	39
20	Function of oxidative stress in the regulation of hematopoietic stem cell-niche interaction Biochemical and Biophysical Research Communications ·Kentaro Hosokawa, Fumio Arai, Hiroki Yoshihara, Yuka Nakamura, Yumiko Gomei, Hiroko Iwasaki, Kana Miyamoto, Haruko Shima, Keisuke Ito, Toshio Suda	2007	86

About Haruko Shima

Haruko Shima is a scholar working on Hematology, Genetics, Rheumatology, Oncology and Immunology, having authored 34 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (10 papers), Chronic Lymphocytic Leukemia Research (7 papers), Eosinophilic Disorders and Syndromes (6 papers), Acute Myeloid Leukemia Research (5 papers), Hematopoietic Stem Cell Transplantation (5 papers), Virus-based gene therapy research (4 papers), CAR-T cell therapy research (3 papers) and Histiocytic Disorders and Treatments (3 papers). The work is most often cited by research in Hematology (593 citations), Genetics (266 citations), Cancer Research (307 citations), Aging (18 citations) and Immunology (207 citations). Haruko Shima has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Toshio Suda, Keiyo Takubo, Wakako Yamada, Nobuhito Goda, Randall S. Johnson, Atsushi Hirao, Makoto Suematsu, Hirono Iriuchishima, Yoshiaki Kubota and Eiji Ikeda. Their work appears in journals such as Pediatric Blood & Cancer, Blood, Journal of Pediatric Hematology/Oncology, International Journal of Hematology and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact